EVELIQURE BIOTECHNOLOGIES GMBH has a total of 16 patent applications. Its first patent ever was published in 2013. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and environmental technology are FEBRIS BIO TECH LTD, YU BAOFA and MAREGADE RX LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Australia | 1 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | EAPO (Eurasian Patent Organization) | 1 | |
#8 | Israel | 1 | |
#9 | India | 1 | |
#10 | Mexico | 1 | |
#11 | Singapore | 1 | |
#12 | United States | 1 | |
#13 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Climate change adaptation technologies | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Nagy Eszter | 13 |
#2 | Szijarto Valeria | 8 |
#3 | Nagy Gabor | 7 |
#4 | Henics Tamas | 7 |
#5 | Henics Tamás | 6 |
#6 | Nagy Gábor | 6 |
#7 | Szijárto Valeria | 5 |
#8 | Eszter Nagy | 1 |
#9 | Valeria Szijárto | 1 |
#10 | Henics Tamas; | 1 |
Publication | Filing date | Title |
---|---|---|
CN104797268A | A novel live attenuated shigella vaccine |